Keytruda Market: Revolutionizing Cancer Treatment with Immunotherapy
Cancer treatment is evolving rapidly with the emergence of innovative immunotherapies. The Keytruda Market is gaining momentum as healthcare providers increasingly adopt this breakthrough therapy to treat multiple cancer types, including melanoma, lung cancer, and head & neck cancers. Keytruda (pembrolizumab) is a monoclonal antibody that blocks the PD-1 pathway, enhancing the immune...
0 Comments 0 Shares 2 Views 0 Reviews